LifeVantage Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US53222K2050
USD
6.97
0.49 (7.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About LifeVantage Corp. stock-summary
stock-summary
LifeVantage Corp.
Pharmaceuticals & Biotechnology
LifeVantage Corporation is focused on bio-hacking the aging code through nutrigenomics. The Company is helping people their health, wellness and financial independence goals. The Company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim Nrf2 synergizer, Protandim NRF1 synergizer, LifeVantage TrueScience, Petandim for dogs, and Axio. It sells products in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands and Germany.
Company Coordinates stock-summary
Company Details
9785 S Monroe St Ste 300 , SANDY UT : 84070-4282
stock-summary
Tel: 1 801 4329000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 14 Schemes (13.86%)

Foreign Institutions

Held by 27 Foreign Institutions (4.04%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Garry Mauro
Independent Chairman of the Board
Mr. Michael Beindorff
Independent Director
Ms. Erin Brockovich
Independent Director
Mr. Raymond Greer
Independent Director
Mr. Vinayak Hegde
Independent Director
Mr. Darwin Lewis
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
55 Million
(Quarterly Results - Jun 2025)
Net Profit:
2 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 145 Million (Micro Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.84%

stock-summary
Debt Equity

-0.53

stock-summary
Return on Equity

28.30%

stock-summary
Price to Book

4.19